We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Initial severity of COVID-19 respiratory failure was ...
A recent study published in the journal PLoS ONE reports that patients with severe coronavirus disease 2019 (COVID-19) are at a higher risk of experiencing persistent pulmonary impairments, even 12 ...
Researchers have found that patients who have idiopathic pulmonary arterial hypertension (IPAH) with a phenotype characterized by a smoking history and low diffusion capacity for carbon monoxide had ...
The FDA has expanded the approval of Jascayd (nerandomilast), an oral phosphodiesterase 4 (PDE4) inhibitor, to include treatment of progressive pulmonary fibrosis in adults.
The Social Security Administration has requested the National Academies of Sciences, Engineering, and Medicine to review the latest published research and science and produce a report addressing best ...
A carboxyhemoglobin test is used to diagnose carbon monoxide poisoning. Carbon monoxide binds to hemoglobin — a protein in red blood cells that transports oxygen. Too much carbon monoxide in your ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback